What changed, Règlement grand-ducal du 6 février 1997 relatif aux substances visées aux tableaux III et IV de la Convention…
2004-10-25 → 2020-12-08 · no interpretation, just the text delta
| on 2004-10-25 | lu-legilux:rgd-1997-02-06-n1:2004-10-25--c11bed9d829f59de5031a0c92a813655a9b4f6f4ea5bff504d0a63b96e0f7371 (2004-10-25 → 2020-12-08) · official source ↗ |
| on 2020-12-08 | lu-legilux:rgd-1997-02-06-n1:2020-12-08--c26fcfa34d7b426e92044f78fb671368f8d9a3442c0fc94c1d26c596a991ba0f (2020-12-08 → 2021-08-15) · official source ↗ |
Open the structured article comparison → matched by provision anchor when continuity is sufficient; otherwise Lex refuses rather than inventing changes
1 line(s) in the old middle, 3 in the new; 61 unchanged leading and 39 trailing lines trimmed.
+ | ETIZOLAM | | (4-(2-chlorophényl)-2-éthyl-9-méthyl-6H-thiéno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazépine) | + | FLUALPRAZOLAM | | (8-chloro-6-(2-fluorophényl)-1-méthyl-4H-[1,2,4,]triazolo[4,3-a][1,4]benzodiazépine) |
| tier | A, publisher-supplied applicability dates |
| history begins | publisher |
| index built | 2026-08-15T09:22:08Z · corpus c087f9153a8cde5429965ffa897db001f3acdf09 |
| stamp signature | valid (ECDSA-P256) |